Contemporary Management of Neuropathic Pain for the Primary Care Physician

Chen, Hsiupei; Lamer, Tim J.; Rho, Richard H.; Marshall, Kenneth A.; Sitzman, B. Todd; Ghazi, Salim M.; Brewer, Randall P.
December 2004
Mayo Clinic Proceedings;Dec2004, Vol. 79 Issue 12, p1533
Academic Journal
Neuropathic pain (NP), caused by a primary lesion or dysfunction in the nervous system, affects approximately 4 million people in the United States each year. It is associated with many diseases, including diabetic peripheral neuropathy, postherpetic neuralgia, human immunodeficiency virus-related disorders, and chronic radiculopathy. Major pathophysiological mechanisms include peripheral sensitization. Unlike most acute pain conditions, NP is extremely difficult to treat successfully with conventional analgesics. This article introduces a contemporary management approach, that is, one that incorporates nonpharmacological, pharmacological, and interventional strategies. Some nonpharmacological management strategies include patient education, physical rehabilitation, psychological techniques, and complementary medicine. Pharmacological strategies include the use of first-line agents that have been supported by randomized controlled trials. Finally, referral to a pain specialist may be indicated for additional assessment, interventional techniques, and rehabilitation. Integrating a comprehensive approach to NP gives the primary care physician and patient the greatest chance for success.


Related Articles

  • Managing neuropathic pain. Poole, Helen // Practice Nurse;4/11/2008, Vol. 35 Issue 7, p19 

    The article describes some of the most common causes of neuropathic pain (NeP) and considers the role of the primary care nurse in its assessment and management. The true prevalence of neuropathic or nerve pain is unknown, but global estimates vary from 2.8-4.7%. NeP is defined as pain in an...

  • Diabetic peripheral neuropathy as a cause of leg pain. Harris, George D. // Patient Care;Jun2006, Vol. 40 Issue 6, p29 

    The article focuses on diabetic peripheral neuropathy (DPN), a common complication of diabetes. DPN could result to different forms of nervous system damage and is the leading cause of morbidity and mortality in diabetic patients. A list of DPN signs and symptoms are included. Risk factors,...

  • TYPES 1 & 2.  // Diabetes Health;Dec2005, Vol. 14 Issue 12, p17 

    Provides clinical information on neuropathic pain in people with diabetes. Cause of neuropathic pain; Prevalence of neuropathic pain in the U.S.

  • Aplicaciones clínicas del ácido tióctico (ácido α-lipoico) en pacientes con neuropatía diabética sintomática: revisión. Brito, Carlos Cantú; Carvallo, Fidel Baizabal; Velasco, Jorge Aldrete; Güitrón, Eduardo Chavez // Medicina Interna de Mexico;mar/abr2007, Vol. 23 Issue 2, p151 

    Diabetes mellitus is the main cause of neuropathy worldwide, being common place for patients to suffer from it at some stage of the disease. Tioctic acid o α-lipoic acid and its related metabolites, due to their antioxidant and chelating properties, have proved an effective therapy for...

  • Structural and Ultrastructural Analysis of Cerebral Cortex, Cerebellum, and Hypothalamus from Diabetic Rats. Hernández-Fonseca, Juan P.; Rincón, Jaimar; Pedreañez, Adriana; Viera, Ninoska; Arcaya, José L.; Carrizo, Edgardo; Mosquera, Jesús // Experimental Diabetes Research;2009, Special section p1 

    Autonomic and peripheral neuropathies are well-described complications in diabetes. Diabetes mellitus is also associated to central nervous system damage. This little-known complication is characterized by impairment of brain functions and electrophysiological changes associated with...

  • Diabetische Neuropathie. Doppler, K.; Reiners, K. // Der Nervenarzt;Feb2015, Vol. 86 Issue 2, p161 

    Background: Diabetic neuropathy is a common complication of diabetes mellitus. The length-dependent symmetrical sensorimotor type of neuropathy is the most prevalent form of diabetic neuropathy but other forms of diabetic neuropathy also need to be kept in mind. Their differential diagnosis is...

  • Small-Fiber Neuropathy. Körei, A. E.; Istenes, I.; Papanas, N.; Kempler, P. // Angiology;Jan2016, Vol. 67 Issue 1, p49 

    Damage of small nerve fibers may lead to a large variety of clinical symptoms. Small-fiber neuropathy underlies the symptoms of painful diabetic neuropathy, which may decrease quality of life. It also contributes to the poor prognosis of diabetic neuropathy because it plays a key role in the...

  • PASS NOTES: Diabetes mellitus -- part one.  // GP: General Practitioner;4/28/2003, p48 

    This article presents several tit bits related to medicine. The prevalence of diagnosed diabetes within the UK is about 3 percent. Treatment of type-2 diabetes accounts for 5 per cent of total NHS resources and 10 per cent of hospital in-patient resources.People with type-2 diabetes are five...

  • US neuropathic pain market set to double by 2018.  // PharmacoEconomics & Outcomes News;9/20/2008, Issue 562, p11 

    The article focuses on the value of the U.S. market for drug treatment of neuropathic pain conditions estimated at $2.6 billion and is predicted to double by 2018, based on the report "US Neuropathic Pain" released by WWMR Inc. The successful launch of pregabalin for diabetic neuropathic pain...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics